• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Study Type: Case-control study

van der Woude Fokke J , Heinemann Lothar A , Graf H, Lewis Michael, Moehner Sabine, Assmann Anita, Kuehl-Habich D, Analgesics use and ESRD in younger age: a case-control study BMC Nephrology. 2007; 8:15.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, No increased risk of colon cancer associated with various HRT formulations: a case-control study BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.
Dinger Jürgen, Assmann Anita, Kuehl-Habich D, The safety of oral hormone replacement therapy under real life conditions: interim results from the EURAS-HRT study. Pharmacoepidemiology and Drug Safety. 2007; 16: S213.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women's Health. 2006; 6:13.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Thiel C, The risk of gynaecological cancers associated with different HRT formulations. A nested case-control study in the German Cohort Study on Women’s Health. Geburth Frauenheilk. 2006; 66:145-155.
Heinemann Lothar A , Garbe E, Lewis Michael, van der Woude F, Graf H, Case-control study on analgesics and nephropathy (SAN): protocol BMC Nephrology. 2005; 6:9 (8 August 2005). DOI: 10.1186/1471-2369-6-9.
Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, Cancer of the uterus and ovary and lifetime history of oral contraceptive use. A German case-control study. Geburth.Frauenheilk. 2003; 63:1018-26.
Heinemann Lothar A , Lewis Michael, Assmann Anita, Thiel C, Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use Contraception. 2002; Mar;65(3):207-14.
Heinemann Lothar A , Kluft C, Spannagl M, De Maat M P M, The association between extrinsic APC resistance and venous thromboembolism in women Contraception. 2002; 66: 297-304.
Follman M, Heinemann Lothar A , Bauerfeind Anja, Garbe E, Treatment with potentially hepatotoxic drugs and the risk of hepatocellular carcinoma: results of a European case - control study. Pharmacoepidemiol Drug Saf . 2000; 9:417-22.
Spannagl M, Heinemann Lothar A , Schramm W, Are FVL carriers using OC at extreme risk for VTE ?. Eur J Contracept Reprod Hlth Care. 2000; 5:105-112.
  • Go to page 1
  • Go to page 2
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.